20 Aug 2026, 05:01 UTC2 viewsread 20 August 2026
📌 猴痘 HIV：猴痘高度“盯上”HIV感染人群 猴痘 HIV：猴痘高度“盯上”HIV感染人群：全球约40%猴痘患者合并HIV感染，共感染住院风险+50%、死亡风险4.54倍。解读共感染风险、两大核心原因及HIV感染者专属防控提醒… 🔗 https://envoymeds.com/archives/6298
Channel
EnvoyMeds
@envoymeds1
On this record: Topic · Growth · Engagement · Posts · Citations · Cite this entry
4subscribers
+1 since we began measuring on 20 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
Register entry
| Telegram ID | -1004239442734 |
|---|---|
| Type | Channel |
| Username | @envoymeds1 |
| Created | 14 August 2026 — measured — dated from the channel’s first post |
| First recorded | 20 August 2026 |
| Last confirmed live | 26 October 2026 |
| Measurements held | 3 |
| Confirmed unchanged | 3 times, most recently 26 October 2026 |
| On Telegram | t.me/envoymeds1 |
Topic
Health & wellness — a classification, not a measurement. An on-box language model (qwen3.6:35b-a3b, prompt version 1) read this channel’s own recent posts on 18 October 2026 and assigned it the closest of 31 fixed categories, at 99% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and the other topics.
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 12 Oct 2026, 08:39 | 4 | +1 |
| 20 Aug 2026, 17:35 | 3 | no change |
| 20 Aug 2026, 09:00 | 3 | first reading |
Engagement
8 posts held, back to 14 August 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 8 posts for this entry, the most recent from 20 August 2026. An engagement rate over an empty window would be a number about nothing.
Recent posts
19 Aug 2026, 12:12 UTC2 viewsread 20 August 2026
📌 耐药 – 一种全新机制的 HIV 药，成了耐药患者的救命稻草 NHS 英格兰正式为对现有药物都耐药、几乎无药可用的 HIV 患者引入全新机制的 lenacapavir（来那卡帕韦）。它直接攻击病毒衣壳，为多重耐药患者带来救命稻草… 🔗 https://envoymeds.com/archives/6317
18 Aug 2026, 09:07 UTC2 viewsread 20 August 2026
📌 HIV 治疗性疫苗：全球首个HIV治疗性疫苗ICVAX，签约无锡了 HIV 治疗性疫苗：全球首个进入临床试验的艾滋病治疗性核酸疫苗ICVAX签约无锡，入选国家十五五重大科技专项。本文深扒其PD-1增强型DNA疫苗原理、港大血统、产业化历程与距离现实的距离… 🔗 https://envoymeds.com/archives/6314
17 Aug 2026, 05:39 UTC2 viewsread 20 August 2026
📌 HIV毒株 – 你我毒株不一样丨135人11种HIV毒株！耐药突变总检出率32.59% HIV毒株：青岛MSM新发HIV感染者病毒测序发现11种毒株，耐药突变总检出率32.59%，新型重组毒株与耐药聚集传播值得警惕… 🔗 https://envoymeds.com/archives/6288
16 Aug 2026, 06:04 UTC2 viewsread 20 August 2026
📌 终结艾滋病：盖茨发文称，终于相信艾滋病能被终结了 比尔·盖茨发文称终于相信艾滋病能被终结：长效预防针剂来那卡帕韦、基因编辑功能性治愈，加上基层医疗网络，让终结艾滋病从口号变成可触及的未来… 🔗 https://envoymeds.com/archives/6287
14 Aug 2026, 20:23 UTC2 viewsread 20 August 2026
📌 治疗即预防 – 应当告知所有医生和感染者：什么是治疗即预防与U=U 治疗即预防（TasP）与U=U：HIV感染者接受抗病毒治疗，将病毒载量维持在＜200拷贝/mL并持续抑制，可预防HIV性行为传播。本文整理自美国DHHS指南，详解7条核心推荐、TasP与U=U的科学边界、病毒学闪现，以及安全套+PrEP+PEP的完整预防链… 🔗 https://envoymeds.com/archives/6273
14 Aug 2026, 20:17 UTC2 viewsread 20 August 2026
📌 HIV 感染者外表：能从外表看出来一个人感染了艾滋吗 HIV 感染者外表：能否从外表判断一个人是否感染HIV？答案是：不能。大多数HIV感染者没有任何症状，外表与普通人毫无差别。确诊只能依靠实验室检测。本文详解HIV感染三阶段、检测窗口期，以及高危暴露后的72小时黄金阻断与正确预防方式… 🔗 https://envoymeds.com/archives/6242
14 Aug 2026, 20:06 UTCviews —
Channel created
Showing the 8 most recent of 8 posts we hold for @envoymeds1. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Mentions
Named by 1 registered channel — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.
Named by
Channels on the register whose posts name this channel's handle.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 12 October 2026 — this entry's latest reading, not the date you are reading this.
“EnvoyMeds” (@envoymeds1), 4 subscribers as measured 12 October 2026. Telegram Register, tgregister.com/channel/envoymeds1.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.